Importantly, there was a negative correlation between the expression of KRT16 and the infiltration of CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells, which is consistent with previous findings and might provide insights into the immunotherapy of melanoma patients. The gene discussed is KRT16; the disease is melanoma.